Accel Diagnostics
A CLIA high-complexity clinical laboratory and developer/manufacturer of disposable, microfluidic point-of-care blood assays and molecular PCR testing. Offers walk-in and appointment-based clinical testing (COVID-19 antigen/PCR/antibody, molecular pathogen panels, drug screens, wellness panels) and research-use disposable assay cards with smartphone-enabled result capture and encrypted cloud storage. Operates clinical research under IRB and provides rapid same-day or expedited turnaround workflows.
Industries
Nr. of Employees
small (1-50)
Accel Diagnostics
Products
Disposable DNA quantitation assay card (research use)
Single-use microfluidic assay for rapid quantitation of double-stranded DNA and PCR products with assay range 2–150 ng/µL, LOD ~2–5 ng/µL, CV ~10%, and 1–2 µL sample volume.
Disposable IgG quantitation assay card (research use)
Mix-and-read disposable assay for rapid quantitation of mouse IgG in cell culture supernatants and other matrices, assay range 2–150 ng/µL, LOD 2–5 ng/µL, CV ~10%, sample volume 1–2 µL.
Disposable smartphone-readable quantitative antibody test (research use / POC development)
Single-use, readerless disposable card intended to provide quantitative antibody titers from a few drops of blood with smartphone readout for trend monitoring and remote clinician review (not FDA-cleared for all uses).
Disposable DNA quantitation assay card (research use)
Single-use microfluidic assay for rapid quantitation of double-stranded DNA and PCR products with assay range 2–150 ng/µL, LOD ~2–5 ng/µL, CV ~10%, and 1–2 µL sample volume.
Disposable IgG quantitation assay card (research use)
Mix-and-read disposable assay for rapid quantitation of mouse IgG in cell culture supernatants and other matrices, assay range 2–150 ng/µL, LOD 2–5 ng/µL, CV ~10%, sample volume 1–2 µL.
Disposable smartphone-readable quantitative antibody test (research use / POC development)
Single-use, readerless disposable card intended to provide quantitative antibody titers from a few drops of blood with smartphone readout for trend monitoring and remote clinician review (not FDA-cleared for all uses).
Services
Clinical diagnostic testing (walk-in and appointment)
On-site patient testing services including COVID-19 antigen/PCR/antibody, influenza testing, STD panels, wellness panels (CBC, metabolic, lipid, thyroid), Quantiferon-TB, and other routine clinical tests.
Molecular PCR pathogen panels
Multiplex PCR panels for urinary tract infection, wound infection, fungal infection, monkeypox and other pathogens with antibiotic resistance marker reporting and same-day result delivery.
Drug and alcohol testing (DOT and non-DOT)
Urine-based multi-panel drug screening (5-, 10-, 14-panel) for individual, employment, and DOT compliance, with confirmatory testing workflow for presumptive positives.
Clinical research study execution (IRB-approved)
Recruitment and sample collection for IRB-approved studies (example: antibody level kinetics after vaccination) with PI oversight and participant compensation.
Clinical diagnostic testing (walk-in and appointment)
On-site patient testing services including COVID-19 antigen/PCR/antibody, influenza testing, STD panels, wellness panels (CBC, metabolic, lipid, thyroid), Quantiferon-TB, and other routine clinical tests.
Molecular PCR pathogen panels
Multiplex PCR panels for urinary tract infection, wound infection, fungal infection, monkeypox and other pathogens with antibiotic resistance marker reporting and same-day result delivery.
Drug and alcohol testing (DOT and non-DOT)
Urine-based multi-panel drug screening (5-, 10-, 14-panel) for individual, employment, and DOT compliance, with confirmatory testing workflow for presumptive positives.
Clinical research study execution (IRB-approved)
Recruitment and sample collection for IRB-approved studies (example: antibody level kinetics after vaccination) with PI oversight and participant compensation.
Expertise Areas
- Point-of-care diagnostics
- Microfluidic assay development
- Molecular PCR panels for infectious disease
- Quantitative serology and biomarker assays
Key Technologies
- Disposable microfluidic assay chips
- Magnetic bead aggregation detection
- Polymerase Chain Reaction (PCR)
- Quantitative immunoassays